Non-Diabetic Clinical Trials

3 recruitingLast updated: May 5, 2026

There are 8 actively recruiting non-diabetic clinical trials across 7 countries. Studies span Not Applicable, Phase 1, Phase 4. Top locations include Baltimore, Maryland, United States, Kunming, Yunnan, China, Odense, Denmark. Updated daily from ClinicalTrials.gov.


Non-Diabetic Trials at a Glance

8 actively recruiting trials for non-diabetic are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Baltimore, Kunming, and Odense. Lead sponsors running non-diabetic studies include BrightGene Bio-Medical Technology Co., Ltd., Odense University Hospital, and Centre Hospitalier Universitaire de la Guadeloupe.

Browse non-diabetic trials by phase

Treatments under study

About Non-Diabetic Clinical Trials

Looking for clinical trials for Non-Diabetic? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Non-Diabetic trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Non-Diabetic clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 1

The Role of Glucagon in Glucose Metabolism in Humans With and Without Bariatric Surgery

Non-Diabetic
The University of Texas Health Science Center at San Antonio150 enrolled2 locationsNCT07212868
Recruiting
Phase 1

A Study of BGM0504 Tablets in Healthy and Non-diabetic Overweight or Obese Chinese Subjects

HealthyNon-diabetic Overweight or Obese
BrightGene Bio-Medical Technology Co., Ltd.75 enrolled1 locationNCT07239973
Recruiting
Not Applicable

Screening for Type 2 Diabetes by Oral Glucose Tolerance Test in the Population Groups Not Diagnosed by Fasting Blood Glucose in Guadeloupe

Non-Diabetic
Centre Hospitalier Universitaire de la Guadeloupe120 enrolled1 locationNCT07233434
Recruiting
Phase 1

Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Tablets in Non-diabetic Overweight or Obese Adult Subjects

Non-diabetic Overweight or Obese
BrightGene Bio-Medical Technology Co., Ltd.80 enrolled1 locationNCT07166081
Recruiting

Triglycerides Glucose Index on Angiographic Profiling of Non-Diabetic Premature Coronary Artery Disease Patients

Coronary Artery DiseaseNon-DiabeticPremature+2 more
Sohag University180 enrolled1 locationNCT07154186
Recruiting
Phase 4

SGLT2i Safety and Efficacy on Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients

Randomized Controlled TrialKidney Transplantation RecipientsSodium-Glucose Transporter 2 Inhibitors+2 more
Odense University Hospital88 enrolled1 locationNCT07143773
Recruiting
Not Applicable

Evaluation of Aqueous Humor DEL-1 and IL-17 Levels in Diabetic Cataract Patients

Diabetic Group (n=30)Non-diabetic Group
Uşak University60 enrolled1 locationNCT06995131
Recruiting
Not Applicable

Glucose Monitoring in Treatment of Postprandial Hypoglycemia After Gastric Bypass Surgery

Hypoglycemia Non-DiabeticGastric Bypass Surgery
Sykehuset i Vestfold HF100 enrolled1 locationNCT06468865